Tigecycline

CAS 220620-09-7 8 current recordsSmall Molecule

Who holds supplier records for Tigecycline? 8 organisations hold a current record for Tigecycline: an active US FDA Type II Drug Master File or a CEP. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Netherlands (1), China (1) and Italy (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tigecycline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tigecycline

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Tigecycline expires 7 Apr 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tigecycline. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Netherlands1China1Italy1Country not recorded for 2
  • GLAND PHARMA LTD
    Active DMF 34296, 25935, 29788 · latest filing Dec 2019
    India Company GMP cert on record
  • WUHAN ZY PHARMACEUTICAL CO LTD
    Active DMF 27696, 37231 · latest filing Jun 2022
  • MELODY HEALTHCARE PVT LTD
    Active DMF 26551 · latest filing Sept 2012
    IndiaCEP
  • TAPI NL BV
    Active DMF 22767 · latest filing May 2009
    NetherlandsCEP
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Active DMF 26311 · latest filing Sept 2012
    ChinaCEP Company GMP cert on record
  • FUAN PHARMACEUTICAL GROUP CO LTD
    Active DMF 27477 · latest filing Aug 2013
  • MAITHRI DRUGS PRIVATE LTD
    Active DMF 30422 · latest filing Mar 2016
    India Company GMP cert on record
  • OLON SPA
    Active DMF 22841 · latest filing Jun 2009
    Italy Company GMP cert on record
Need Tigecycline sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Tigecycline, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TAPI NL B.V. AmsterdamNL
CEP 2018-130 - Rev 03
Tigecycline, Form II
Jan 2026—
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2024-176 - Rev 01
Tigecycline
Nov 2025—
MELODY HEALTHCARE PVT. LTD. MumbaiIN
CEP 2018-056 - Rev 04
Tigecycline
Mar 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (6 listed products contain Tigecycline). The latest listed patent expires 7 Apr 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Tigecycline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL376140).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Tetracycline-class Antibacterial
Chemical structure
Tetracyclines

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tigecycline?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Tigecycline: GLAND PHARMA LTD (India), WUHAN ZY PHARMACEUTICAL CO LTD, MELODY HEALTHCARE PVT LTD (India), TAPI NL BV (Netherlands), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), FUAN PHARMACEUTICAL GROUP CO LTD, MAITHRI DRUGS PRIVATE LTD (India) and OLON SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tigecycline Drug Master Files are active?

GLAND PHARMA LTD (DMF 34296, 25935), WUHAN ZY PHARMACEUTICAL CO LTD (DMF 27696, 37231), MELODY HEALTHCARE PVT LTD (DMF 26551), TAPI NL BV (DMF 22767), Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 26311), FUAN PHARMACEUTICAL GROUP CO LTD (DMF 27477), MAITHRI DRUGS PRIVATE LTD (DMF 30422) and OLON SPA (DMF 22841). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Tigecycline have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Tigecycline on the EDQM register, including TAPI NL B.V. Amsterdam (NL), ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou City (CN) and MELODY HEALTHCARE PVT. LTD. Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Tigecycline?

Yes. The latest patent listed for an approved US product containing Tigecycline expires 7 Apr 2033, across 6 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Tigecycline supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tigecycline?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.